Butrón-Bris, B, Llamas-Velasco, M, Armesto, S, Sahuquillo-Torralba, A, Pujol-Montcusi, J, Ruiz-Villaverde, R, Martinez-López, A, de la Cueva, P, Romero-Mate, A, Roustan, G, Vilarrasa-Rull, E, Ferrán-Farres, M, Ovejero-Benito, MC, Palomar-Moreno, C, Navares, M, Novalbos, J, Abad-Santos, F, Dauden, E, de la Fuente, H. Genetic Polymorphisms in Psoriasis: Investigating Genetic Variations for Precise Profiling of Response to Brodalumab in Real-Life Clinical Practice. Actas Dermo-Sifiliograficas. 2025; 116(8)DOI:10.1016/j.ad.2025.03.030. PMID:40246146. IF:(Q/D).

Wollenberg, A, Kinberger, M, Arents, B, Aszodi, N, Barbarot, S, Bieber, T, Brough, HA, Calzavara-Pinton, P, Christen-Zaech, S, Deleuran, M, Dittmann, M, Fosse, N, Gáspár, K, Gerbens, LAA, Gieler, U, Girolomoni, G, Gregoriou, S, Holland, S, Mortz, CG, Nast, A, Nygaard, U, Rehbinder, EM, Ring, J, Rossi, M, Serra-Baldrich, E, Simon, D, Szalai, ZZ, Szepietowski, JC, Torrelo, A, Werfel, T, Werner, RN, Flohr, C. European Guideline (EuroGuiDerm) on atopic eczema: Living update. JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY. 2025; 39(9)DOI:10.1111/jdv.20639. PMID:40317496. IF:8.000(Q1/1D).

Gkini, MA, López-Ferrer, A, Magnolo, N, Soung, J, Trafford, A, Pousa, ID, Kavanagh, S, Gooderham, M. Bimekizumab efficacy in patients with plaque psoriasis: A post hoc stratification by weight over 4 years in BE BRIGHT. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY. 2025; 93(3)DOI:. PMID:. IF:11.800(Q1/1D).

Blauvelt, A, Langley, RG, Lebwohl, M, Strober, B, Warren, RB, Puig, L, Morita, A, Gordon, KB, Fernandez-Peña, P, Kavanagh, S, Pinto, JML, Lambert, J, Hoepken, B, Deherder, D, Cross, N, Thaçi, D. Bimekizumab durability of efficacy through 196 weeks and safety through 4 years in patients with moderate to severe plaque psoriasis: Results from the BE BRIGHT open-label extension trial. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY. 2025; 93(3)DOI:10.1016/j.jaad.2025.04.038. PMID:40286813. IF:11.800(Q1/1D).

Cantó, E, del Prado, ME, Vilarrasa, E, López-Ferrer, A, de Aranibar, FJGL, Ortiz, MA, Gut, M, Mulet, M, Esteve-Codina, A, Osuna-Gómez, R, Guinart-Cuadra, A, Puig, L, Vidal, S. Transcriptomic Identification of Immune-Related Hubs as Candidate Predictor Biomarkers of Therapeutic Response in Psoriasis. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES. 2025; 26(17)DOI:10.3390/ijms26178118. PMID:40943056. IF:4.900(Q1/3D).

Salgado-Boquete, L, Puig, L, Carrascosa, JM, de la Cueva, P, Ferrer, AL. Updated Perspective from the Spanish Psoriasis Working Group (GPS) on Biosimilar Drug Use in Moderate-to-Severe Psoriasis. Actas Dermo-Sifiliograficas. 2025; 116(7)DOI:10.1016/j.ad.2025.05.011. PMID:40446921. IF:(Q/D).

Dobao, PD, Barredo, LC, Salvador, JFS, Serra-Baldrich, E, Pinto, PH, Cano, NH, De Frutos, FJO, Gullón, GR, Belloso, RML, Ortega, IA, Quesada, AG, Gutiérrez, MG, Calzada, YG, Torredemer, DA, Felius, NL, Martin, IH, Laserna, FJR. Patient Burden and Impact of Moderate-to-Severe Atopic Dermatitis in the Spanish Healthcare System: The APOLO Cross-Sectional Study. Dermatology Practical & Conceptual. 2025; 15(3)DOI:10.5826/dpc.1503a5538. PMID:40790435. IF:2.300(Q2/5D).

Cheon, JH, Ye, BD, Armuzzi, A, Rieder, F, Girolomoni, G, Puig, L, Jung, HJ, Feldman, SR. The 'totality of evidence' and 'extrapolation' of SB17, a ustekinumab biosimilar. EXPERT OPINION ON BIOLOGICAL THERAPY. 2025; 25(6)DOI:10.1080/14712598.2025.2508838. PMID:40396611. IF:4.000(Q2/3D).

Ferrer, AL. Current Challenges in Dermatology Residency Training. Actas Dermo-Sifiliograficas. 2025; 116(6)DOI:10.1016/j.ad.2025.03.021. PMID:. IF:(Q/D).

Angel-Baldo, J, Podlipnik, S, Azón, A, Boada, A, Arrieta, A, Marcoval, J, López-Sánchez, C, Sàbat , M, Segura, S, Bodet, D, Sabat, M, Curcó, N, Lopez-Castillo, D, Solà, J, Quintana-Codina, M, Baliu-Piqué, C, Martin-Sala, S, Just-Sarobé, M, Martín-Sala, S, Malvehy, J, Puig, S, Carrera, C, Marti, RM. Acral Melanoma in the Caucasian Population: A Comprehensive Cohort Study on Epidemiological, Clinicopathological, and Prognostic Features. Actas Dermo-Sifiliograficas. 2025; 116(5)DOI:10.1016/j.ad.2024.10.060. PMID:39798598. IF:(Q/D).

Serra-Baldrich, E, Armstrong, AW, Festini, T, Ivens, U, Nielsen, IV, Wiseman, M, Krüger-Szabo, A. RW effectiveness of tralokinumab in adults with atopic dermatitis on the genitals: Interim data on improvements in physician-assessed disease severity and PRO in up to 3 months of treatment (TRACE). JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT. 2025; 23DOI:. PMID:. IF:3.800(Q1/2D).

Escanilla, C, Schroder, C, Garrido, V, Balague, M, Ruiz, V, Toscas, JI, Cevallos, C. Anterior Thoracic Trichilemmal Carcinoma: A Rare Case with a Novel Treatment. REVISTA MEDICA DE CHILE. 2025; 153(4)DOI:10.4067/s0034-98872025000400310. PMID:40493479. IF:0.300(Q4/8D).

Augustin, M, Serra-Baldrich, E, Seneschal, J, Elrayes, M, Otero-Asman, JR, Berkery, E, Fakouri, W, Bewley, A, Garcia-Latasa, J, Pinter, A, Schlöbe, A. Clin. eff. & PROs in mod.-sev. AD pts treated w/ oral systemics: 12-wk interim results from AD-REAL focusing on pts w/ BSA 7 ('itch dominant'). JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT. 2025; 23DOI:. PMID:. IF:3.800(Q1/2D).

Serra-Baldrich, E, Armstrong, AW, Festini, T, Ivens, U, Nielsen, IV, Wiseman, M, Krüger-Szabo, A. RWeffectiveness of tralokinumab in adults with atopic dermatitis on the genitals: Interim data on improvements in physician-assessed disease severity and PRO in up to 3 months of treatment ( TRACE). JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT. 2025; 23DOI:. PMID:. IF:3.800(Q1/2D).

Augustin, M, Serra-Baldrich, E, Seneschal, J, Elrayes, M, Otero-Asman, JR, Berkery, E, Fakouri, W, Bewley, A, García-Latasa, J, Pinter, A, Schlöbe, A. Clin. eff. & PROs inmod.-sev. AD pts treated w/ oral systemics: 12-wk interim results from AD-REAL focusing on pts w/ BSA 7 ('itch dominant'). JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT. 2025; 23DOI:. PMID:. IF:3.800(Q1/2D).

Vestergaard, C, Thaci, D, Puig, L, Papp, KA, Gold, LS, Peñas, PF, Huan, YH, Dossenbach, M, Falques, M, Agell, H, Du Jardin, KG. MEAN ABSOLUTE EASI AND PRURITUS ACHIEVED BY LEBRIKIZUMAB OVER 16 WEEKS IN PATIENTS WITH MODERATE-TO-SEVERE ATOPIC DERMATITIS. ACTA DERMATO-VENEREOLOGICA. 2025; 105DOI:. PMID:. IF:3.700(Q1/2D).

Ceravalls, J, Gímenez-Arnau, AM, Expósito-Serrano,, Chico, NF, Moya, AL, Bielsa,, Ribó, P, Mascaro-Hereza, B, Bonfill-Orti, M, Spertino, J, Serra, E, Baliu-Pique, C, Mele-Ninot, G. Predictive Factors and Optimization of Omalizumab in Chronic Spontaneous Urticaria: A Multicenter Study of 257 Patients. JOURNAL OF INVESTIGATIONAL ALLERGOLOGY AND CLINICAL IMMUNOLOGY. 2025; 35(3)DOI:10.18176/jiaci.1053. PMID:39950575. IF:4.800(Q1/1D).

Argenziano G, Cusano F, Corazza M, Amato S, Amerio P, Naldi L, Patruno C, Pigatto PD, Quaglino P, Gisondi P, Chiricozzi A, Tonon F, Stingeni L, Calzavara-Pinton P, Wollenberg A, Kinberger M, Arents BW, Aszodi N, Avila Valle GL, Barbarot S, Bieber T, Brough HA, Christen-Zäch S, Deleuran M, Dittmann M, Dressler C, Fink-Wagner AH, Fosse N, Gáspár K, Gerbens LA, Gieler U, Girolomoni G, Gregoriou S, Mortz CG, Nast A, Nygaard U, Redding M, Rehbinder EM, Ring J, Rossi M, Serra-Baldrich E, Simon D, Szala I ZZ, Szepietowski JC, Torrelo A, Werfel T, Flohr C. Italian S3-Guideline on the treatment of Atopic Eczema - Part 2: non-systemic treatments and treatment recommendations for special AE patient populations, adapted from EuroGuiDerm by the Italian Society of Dermatology and STD (SIDEMAST), the Italian Association of Hospital Dermatologists (ADOI) and the Italian Society of Allergological and Occupational Dermatology (SIDAPA).. Italian Journal of Dermatology and Venereology. 2024; 159(3)DOI:10.23736/S2784-8671.24.07666-7. PMID:38727634. IF:(Q/D).

Navarro-Triviño FJ, Borrego L, Silvestre-Salvador JF, Mercader-García P, Giménez-Arnau AM, Ortiz-de Frutos FJ, Sanz-Sánchez T, Melé-Ninot G, Sánchez-Gilo A, Zaragoza-Ninet V, Serra-Baldrich E, Miquel-Miquel J, Córdoba-Guijarro S, Rodríguez-Serna M, Ruíz-González I, Carrascosa-Carrillo JM, Gómez-de la Fuente E, Pastor-Nieto MA, Heras-Mendaza F, González-Pérez R, Sánchez-Pedreño Guillén P, Sánchez-Pérez J, Gatica-Ortega ME, Fernández-Redondo V, Hervella-Garcés M, Manrique-Martínez P, Guimaraens-Juanena D, García-Gavín J, Giménez-Arnau E, Figueras-Nart I, Curto-Barredo L, Armario-Hita JC. [Translated article] Standard and Expanded Series Patch Testing Update by the Spanish Contact Dermatitis and Skin Allergy Research Group (GEIDAC).. Actas Dermo-Sifiliograficas. 2024; 115(7)DOI:10.1016/j.ad.2024.05.018. PMID:38823769. IF:(Q/D).

Mateu-Arrom L, Garcia-Muret MP, Conforto GC, Puig L. Tofacitinib Use in the Treatment of Plantar Erosive Lichen Planus.. INDIAN JOURNAL OF DERMATOLOGY. 2024; 68(6)DOI:10.4103/ijd.ijd_512_23. PMID:38371534. IF:(Q/D).